Blog
GLP-1 Peptides Weight Loss Comparison Chart
Feb
GLP-1 Peptides Weight Loss Comparison Chart: Effectiveness, Dosage, Results & Safety (2026)
Quick Answer: GLP-1 Peptides Weight Loss Comparison
GLP-1 peptides like retatrutide, tirzepatide, and semaglutide are among the most effective metabolic peptides available today. Retatrutide ranks highest due to its triple receptor mechanism, followed closely by tirzepatide (dual receptor) and semaglutide (GLP-1 only). Each peptide varies in dosage, results timeline, and side effect profile, which makes comparison charts crucial for choosing the right option.
Why Compare GLP-1 Peptides for Weight Loss?
GLP-1 peptides are revolutionizing metabolic health:
-
Reduce appetite and cravings
-
Improve metabolic efficiency
-
Support fat loss over time
People often struggle to choose because:
-
Multiple peptides exist
-
Each has different mechanisms
-
Dosage schedules differ
-
Results and side effects vary
A visual comparison chart simplifies decision-making and improves research clarity.
GLP-1 Peptides Weight Loss Comparison Chart
| Peptide | Mechanism | Typical Weekly Dose | Effectiveness | Research Support | Common Side Effects |
|---|---|---|---|---|---|
| Retatrutide | GLP-1 + GIP + Glucagon (triple) | 5–15 mg | Extremely High | Strong but emerging | Nausea, mild digestive discomfort |
| Tirzepatide | GLP-1 + GIP (dual) | 2.5–15 mg | Very High | Extensive | Nausea, fatigue, occasional diarrhea |
| Semaglutide | GLP-1 only | 0.25–2 mg | Very High | Extensive | Nausea, constipation, headache |
| Cagrilintide | Amylin analog | 2–4 mg | High | Growing | Nausea, fullness |
| Exenatide | GLP-1 only | 5–10 μg | Moderate | Established | Nausea, vomiting |
| Liraglutide | GLP-1 only | 0.6–3 mg | High | Strong | Nausea, vomiting, headache |
Tip: Use this chart to quickly assess peptide strength, dosage, and tolerability.
Dosage & Results Timeline Comparison
Understanding the progression is key to planning expectations.
| Peptide | Weeks 1–4 | Weeks 5–8 | Weeks 9–12 | Maintenance Phase |
|---|---|---|---|---|
| Retatrutide | Starting dose, early adaptation | Increased dose, appetite reduction | Active fat loss | Target dose, long-term stability |
| Tirzepatide | Initial dose, mild appetite suppression | Increased dose, noticeable changes | Active weight loss | Target dose, long-term consistency |
| Semaglutide | Low starting dose | Moderate appetite control | Visible fat loss | Maintenance dose, sustained results |
| Cagrilintide | Initial dose, full signals | Appetite regulation | Moderate results | Maintenance, stabilized effect |
| Exenatide | Low dose adaptation | Gradual effect | Slow results | Maintenance, mild effect |
| Liraglutide | Low dose adaptation | Appetite control | Moderate results | Maintenance, stable results |
This table helps users anticipate when changes occur and adjust their routine accordingly.
Mechanism Deep Dive: Why Retatrutide Ranks Highest
-
Activates three receptors: GLP-1, GIP, and Glucagon
-
Broader metabolic influence than dual or single receptor peptides
-
Provides the fastest appetite suppression and fat loss potential
-
Clinical research shows superior reduction in body weight vs others
Tirzepatide vs Semaglutide
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Receptors | Dual (GLP-1 + GIP) | Single (GLP-1) |
| Appetite Suppression | Strong | Moderate-Strong |
| Fat Loss Potential | Very High | High |
| Research Depth | Strong | Extensive |
| Side Effects | Nausea, mild fatigue | Nausea, constipation |
Tirzepatide offers slightly better weight loss due to dual receptor action, but semaglutide is highly trusted for consistent results.
Safety & Side Effect Comparison
| Peptide | Most Common Side Effects | Notes |
|---|---|---|
| Retatrutide | Mild nausea, digestive discomfort | Typically resolves with titration |
| Tirzepatide | Nausea, diarrhea, fatigue | Dose-dependent, manageable |
| Semaglutide | Nausea, constipation, headache | Start low, increase gradually |
| Cagrilintide | Nausea, fullness | Usually mild |
| Exenatide | Nausea, vomiting | Shorter duration, requires multiple injections |
| Liraglutide | Nausea, vomiting | Dose titration advised |
Gradual dose escalation is critical for reducing side effects.
Beginner-Friendly GLP-1 Peptide Chart
| Goal | Best Choice | Notes |
|---|---|---|
| Maximum weight loss | Retatrutide | Triple receptor, fastest results |
| Proven track record | Tirzepatide | Dual receptor, extensively studied |
| Consistency & tolerability | Semaglutide | Widely used, strong support |
| Appetite signaling | Cagrilintide | Amylin analog, good for meal control |
| Low starting dose | Exenatide | Mild effects, good for beginners |
| Established long-term | Liraglutide | Safe, widely researched |
This chart simplifies decision-making for beginners.
Factors That Affect GLP-1 Peptide Effectiveness
-
Consistency: Weekly injections must be on schedule
-
Lifestyle: Diet and exercise dramatically improve results
-
Metabolism: Individual variability affects results timeline
-
Tolerance: Side effect management may require slower titration
Following the proper protocol ensures maximum effectiveness.
Frequently Asked Questions
Which GLP-1 peptide is strongest?
Retatrutide ranks highest due to its triple receptor action.
How fast do these peptides work?
Visible changes usually appear 4–12 weeks, depending on peptide and dosage.
Can I switch between peptides?
Yes, but consult healthcare providers for proper transition and dosing adjustments.
Are side effects severe?
Most are mild to moderate and reduce over time with gradual titration.
Key Takeaways: GLP-1 Peptide Comparison
-
Retatrutide: Strongest, fastest weight loss
-
Tirzepatide: Dual-action, proven track record
-
Semaglutide: Widely used, consistent results
-
Cagrilintide: Focused on appetite control
-
Exenatide & Liraglutide: Established, moderate weight loss
Using charts like this helps plan, compare, and choose the most suitable GLP-1 peptide.
